medigraphic.com
Órgano Oficial del Instituto Nacional de Pediatría

2009, Number 3

<< Back Next >>

Acta Pediatr Mex 2009; 30 (3)

Obesity and comorbidities in children and adolescents at the Instituto Nacional de Pediatría

Perea-Martínez A, Bárcena-Sobrino E, Rodríguez-Herrera R, Greenawalt-Rodríguez S, Carbajal-Rodríguez L, Zarco-Román J

Language: Spanish
References: 41
Page: 167-174
PDF size: 539.75 Kb.


ABSTRACT

Obesity is an inflammatory, systemic, chronic and recurrent disease. It produces metabolic and non-metabolic complications. The most frequent metabolic complications are type 2 diabetes mellitus and dyslipidemia. Non metabolic complications include systemic arterial hypertension, hypoventilation syndrome, sleep apnea obstructive syndrome, fatty hepatic disease, orthopedic damage, social-psychological disorders. Their individual incidence differs. For this reason they should be investigated, because in most cases patients are asymptomatic.


REFERENCES

  1. World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: World Health Organization. 1997.

  2. International Obesity Task Force data, based on populationweighted estimates from Published and unpublished surveys, 1990-2002 using IOTF-recommended cut-offs for overweight and obesity. http: //www.iotf.org.

  3. Hedley AA, Odgen CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 2004;291:2847-50.

  4. Calzada LR. Prevalencia y etiopatogenia. En: Calzada LR. Obesidad en niños y adolescentes. 1ª Ed. México: Editores de Textos Mexicanos; 2003.

  5. Del Río NB, Velásquez MO, Sánchez CC, Lara EA, Berber A, Fanghanel G. The high prevalence of overweight and obesity in Mexican children. Obes Res 2004;12:215-23.

  6. Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S, Hernández M, Sepúlveda J. Encuesta Nacional de Salud y Nutrición. Instituto Nacional de Salud Pública. Secretaría de Salud. México 2006.

  7. Srinivasan SR, Myers L, Berenson GS. Adolescent overweight is associated with adult overweight and related multiple cardiovascular risk factors: The Bogalusa Heart Study. Metabolism 1996;45:235-40.

  8. Srinivasan SR, Myers L, Berenson GS. Predictability of childhood adiposity and insulin for developing insulin resistance syndrome (syndrome X) in young adulthood: the Bogalusa Heart Study. Diabetes 2002;51:204-9.

  9. Must A, Jacques PF, Dallal GE, Bajeza CJ, Dietz WH. Long term morbidity and mortality of overweight adolescents: a follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327:1350-5.

  10. García ML. Síndrome Metabólico en Pediatría. En: PAC Pediatría VI. Academia Mexicana de Pediatría 2006;3:105-14.

  11. Dorantes AL. Diabetes mellitus tipo 2. En: PAC Pediatría VI. Academia Mexicana de Pediatría 2006;3:115-27.

  12. Rodríguez HR, Carbajal RL, García-de la Puente S, Zarco RJ, Perea MA. Hipertensión arterial sistémica en niños. Act Pediatr Mex 2008;29:89-101.

  13. Daniels SR, Arnett DK, Eckel RH, Gidding SS, Hayman LL, Kumanyika S, et al. Overweight in children and adolescents. Pathophysiology, consequences, prevention and treatment. Circulation 2005;111:1999-2012.

  14. Cook S, Weitzman M, Auiger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med 2003;157:821-7.

  15. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep 2004;4:53-62.

  16. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation 2004;110:2494-7.

  17. Goodman F, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence and demographic disparities in the World Health Organization and National Cholesterol Education Program. Adult Treatment Panel III. Definitions of metabolic syndrome among adolescents. J Pediatr 2004;145:445-51.

  18. Goodman E, Whitaker RC. A prospective study of the role of depression in the development and persistence of adolescent obesity. Pediatrics 2002;110:497-504.

  19. Strauss RS, Pollack HA. Social marginalization of overweight children. Arch Pediatr Adolesc Med 2003;157:746-52.

  20. Schechter MS. Section on Pediatric Pulmonology, Subcommittee on Obstructive Sleep Apnea Syndrome. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:e69.

  21. Gami AS, Caples SM, Somers VK. Obesity and obstructive sleep apnea. Endocrinol Metab Clin N Am 2003;32:869-94.

  22. Wilcox PG, Weiner DS, Leighley B. Maturation factors in slipped capital femoral epiphysis. J Pediatr Orthop 1988;8:196-200.

  23. Sowers MF. Epidemiology of risk factors for osteoarthritis: systemic factors. Curr Opin Rheumatol 2001;13:447-51.

  24. Harrison SA, Dile AM. Fat and the liver–a molecular overview. Semin Gastrointest Dis 2002;13:3-6.

  25. Tazawa Y, Noguchi H, Nishinomiya F, Takada G. Serum alanine aminotransferases activity in obese children. Acta Pediatr 1997;86:238-41.

  26. Crichlow RW, Seltzer MH, Jannetta PJ. Colecistitis in adolescents. Am J Dig Dis 1972;17:68-72.

  27. National on High Blood Pressure Education Program. Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(suppl):555-76.

  28. Ogden CL, Carroll MD, Flegal KM. Epidemiologic trends in overweight and obesity. Endocrinol Metab Clin North Am 2003; 32: 741-60.

  29. Ogden CL, Flegal KM, Carroll MD, et al. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-32.

  30. Kenny S, Aubert R, Geiss L. Prevalence and incidence of non-insulin dependent diabetes. In: Harris M, Cowie C, Stern M, et al. Eds. Diabetes in America , 2nd ed. Bethesda, MD: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases. 1995.p.47-68.

  31. Barker DJP. Fetal programming of coronary heart disease. Endocrinol Metab 2002;13:364-8.

  32. Li C, Johnson MS, Goran MI. Effects of low birth weight on insulin resistance syndrome in white and African-American children. Diabetes Care 2001;24:2035-42.

  33. Martin H, Hu J, Gennser G, et al. Impaired endothelial function and increased carotid stiffness in 9-year-old children with low birth weight. Circulation 2000;102:2739-44.

  34. Forsen T, Eriksson J, Toumilehto J, et al. The fetal and childhood growth of persons who develop type 2 diabetes. Ann Intern Med 2000;133:176-82.

  35. Sorof JM, Poffenberger T, Franco K, Bernard L, Partnean R. Isolated systolic hypertension, obesity, and hyperkinetic hemodynamic states in children. J Pediatr 2002;140:660-6.

  36. Invitti C, Guzzaloni G, Gilardini L, Morabito F, Viberti G. Prevalence and concomitant of glucose intolerance in European obese children and adolescents. Diabetes Care 2003;26:118-24.

  37. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999;103:1175-82.

  38. Ibanez L, Dimartino-Nardi J, Potau N, Saenger P. Premature adrenarche–normal variant of forerunner of adult disease? Endocr Rev 2002;21:671-96.

  39. Michelmore KF, Balen AH, Dunger DB, Vessey MP. Polycystic ovaries and associated clinical and biochemical features in young women. Clin Endocrinol (Oxf) 1999;51:779-86.

  40. Schwimmer JB, Burwinkle TM, Varna JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003;289:1813-19.

  41. Strauss RS, Pollack HA. Social marginalization of overweight children. Arch Pediatr Adolesc Med 2003;157:746-53.




2020     |     www.medigraphic.com